EAGLE PHARMACEUTICALS INC shareholders Q3 2023

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
GSA CAPITAL PARTNERS LLP 25,446$4010.03%
Stanley-Laman Group, Ltd. 12,000$189,2400.03%
Trexquant Investment LP 67,187$1,059,5390.03%
CONNORS INVESTOR SERVICES INC 12,566$1980.02%
ClariVest Asset Management LLC 22,262$3510.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$7,885,0000.02%
Headlands Technologies LLC 2,326$36,6810.02%
ACADIAN ASSET MANAGEMENT LLC 236,902$3,7330.02%
LSV ASSET MANAGEMENT 408,758$6,4460.02%
KENNEDY CAPITAL MANAGEMENT LLC 36,486$575,3840.01%
External links

This page lists EAGLE PHARMACEUTICALS INC's shareholders in Q3 2023. To view EAGLE PHARMACEUTICALS INC's shareholder history, click here.